Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2024-06-17 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 100% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares of a listed company, including share issuance under equity plans and share repurchases. It references specific Hong Kong Stock Exchange Listing Rules (Main Board and GEM) sections 13.25A, 17.27A, 10.06(4)(a), and others, which govern disclosure of share capital changes. The document includes tables of share counts before and after events, prices, and confirmations of compliance with listing rules. It is not an announcement of a report publication but the actual disclosure report itself. This type of document corresponds to a Share Issue/Capital Change announcement, as it details share issuance and treasury share movements under regulatory requirements.
2024-06-17 Chinese
港股公告：授出购股权、受限制股份单位及业绩股份单位
Director's Dealing Classification · 95% confidence The document is a detailed announcement regarding the grant of share options, restricted stock units, and performance stock units under the 2016 Option and Incentive Plan by BeiGene, Ltd. It includes specifics about the number of shares granted, vesting schedules, exercise prices, recipients including directors and employees, and related policies. The document references compliance with Hong Kong Stock Exchange Listing Rules (e.g., rules 17.06A, 17.06B, 17.06C) and discloses insider grants to directors and senior executives. This type of disclosure is typical of a Director's Dealing report, which involves personal share transactions or grants to company directors and executives. It is not an earnings release, annual report, or other financial report, nor is it a proxy solicitation or voting result announcement. The document is substantive and detailed, not a brief announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-06-12 Chinese
港股公告：证券变动月报表
Capital/Financing Update Classification · 95% confidence The document is a monthly securities movement report submitted to the Hong Kong Stock Exchange, detailing changes in registered capital, issued shares, share options, and confirmations related to share issuance compliance under the Listing Rules Chapter 19B. It includes detailed tables of share counts, share option plans, and confirmations by the executive director. The document is titled as a monthly report on securities changes and does not contain financial statements, earnings data, or management discussion. It is a regulatory compliance filing related to share capital changes and share issuance confirmations, typical of a capital/financing update. The document length is 4740 characters, which is substantive and contains detailed data, not just an announcement or certification. Therefore, the best fitting category is Capital/Financing Update (CAP).
2024-06-06 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 100% confidence The document is a disclosure report related to changes in issued share capital and/or share repurchases by the company, as required under the Hong Kong Stock Exchange Listing Rules (Main Board Rule 13.25A and GEM Rule 17.27A). It details share issuance under a share award plan, including dates, share counts, prices, and percentage changes in issued shares. The document includes formal confirmations by the company's board and executive director regarding the authorization and compliance of the share issuance. The content is regulatory disclosure about share capital changes rather than a full financial report or announcement of a report. This fits the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or capital changes.
2024-06-06 Chinese
美股公告：表格S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 registration statement filed with the U.S. Securities and Exchange Commission (SEC) by BeiGene, Ltd. on June 5, 2024. It registers additional shares under the company's 2016 Stock Option and Incentive Plan and 2018 Employee Stock Purchase Plan. The document includes legal opinions, auditor consents, and registration fee calculations. Form S-8 is specifically used for registering securities to be offered under employee benefit plans. This filing is a capital/financing update related to the registration of new shares for employee stock plans, not a financial report or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2024-06-06 Chinese
百济神州有限公司2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 Annual General Meeting (AGM) of BeiGene Ltd. It includes information about the meeting date, location, attendance, voting results on various proposals including director elections, auditor appointments, share issuance authorizations, and executive compensation. The document also contains legal opinions confirming the validity of the meeting and voting procedures. There is no indication that this is the full annual report or financial statements, but rather a formal disclosure of the AGM voting results and related information. The document length is substantial and contains detailed voting data, which is typical for a Declaration of Voting Results & Voting Rights Announcements filing. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2024-06-06 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.